Renal Denervation and Symplicity HTN-3 "Dubium Sapientiae Initium" (Doubt Is the Beginning of Wisdom)

被引：37
|
作者：
Papademetriou, Vasilios [1 ,2 ]
Tsioufis, Costas [3 ]
Doumas, Michael [4 ]
机构：
[1] Vet Affairs Med Ctr, Dept Med Cardiol, Washington, DC 20422 USA
[2] Georgetown Univ, Washington, DC USA
[3] Kapodestrian Univ Athens, Dept Cardiol, Athens, Greece
[4] Aristotle Univ Thessaloniki, Dept Med, GR-54006 Thessaloniki, Greece
来源：
CIRCULATION RESEARCH | 2014年 / 115卷 / 02期
关键词：
AMBULATORY BLOOD-PRESSURE; SYMPATHETIC DENERVATION; RESISTANT HYPERTENSION; NERVE-STIMULATION; ABLATION; CATHETER; SYSTEM; FUTURE;
D O I：
10.1161/CIRCRESAHA.115.304099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：211 / 214
页数：4
相关论文
共 50 条
  • [41] HYPERTENSION How should data from SYMPLICITY HTN-3 be interpreted?
    Schmieder, Roland E.
    NATURE REVIEWS CARDIOLOGY, 2014, 11 (07) : 375 - 376
  • [42] 12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension The SYMPLICITY HTN-3 Trial
    Bakris, George L.
    Townsend, Raymond R.
    Flack, John M.
    Brar, Sandeep
    Cohen, Sidney A.
    D'Agostino, Ralph
    Kandzari, David E.
    Katzen, Barry T.
    Leon, Martin B.
    Mauri, Laura
    Negoita, Manuela
    O'Neill, William W.
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (13) : 1314 - 1321
  • [43] Potential reduction in office and nocturnal blood pressure after renal denervation in patients with obstructive sleep apnea: a subgroup analysis of SYMPLICITY HTN-3
    Kario, K.
    Bhatt, D.
    Townsend, R.
    Flack, J.
    Negoita, M.
    Oparil, S.
    Bakris, G.
    EUROPEAN HEART JOURNAL, 2015, 36 : 186 - 186
  • [44] Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry
    Mahfoud, Felix
    Bakris, George
    Bhatt, Deepak L.
    Esler, Murray
    Ewen, Sebastian
    Fahy, Martin
    Kandzari, David
    Kario, Kazuomi
    Mancia, Giuseppe
    Weber, Michael
    Boehm, Michael
    EUROPEAN HEART JOURNAL, 2017, 38 (02) : 93 - 100
  • [45] Regression to the Mean in SYMPLICITY HTN-3 Implications for Design and Reporting of Future Trials
    Pocock, Stuart J.
    Bakris, George
    Bhatt, Deepak L.
    Brar, Sandeep
    Fahy, Martin
    Gersh, Bernard J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : 2016 - 2025
  • [46] Benefits of renal denervation persist at 3 years—data from Symplicity HTN-1
    Nature Reviews Cardiology, 2014, 11 (1) : 2 - 2
  • [47] Renal denervation for resistant hypertension-the Symplicity HTN-1 study
    Wang, Yutang
    LANCET, 2014, 383 (9932): : 1885 - 1885
  • [48] Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings
    Esler, Murray
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (08) : 593 - 598
  • [49] Long-term (24-month) blood pressure results of catheter-based renal artery denervation: SYMPLICITY HTN-3 Randomized Controlled Trial
    Bhatt, Deepak L.
    Bakris, George L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B38 - B39
  • [50] High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3
    Waksman, Ron
    Bakris, George L.
    Steinvil, Arie
    Garcia-Garcia, Hector
    Brown, Angela L.
    DiFilippo, William
    Scott, Thomas
    Singh, Jasvindar
    DeBruin, Vanessa
    Jones, Denise
    Jolivette, Dan
    Bhatt, Deepak L.
    AMERICAN HEART JOURNAL, 2017, 192 : 76 - 84
12345